Anaplastic thyroid carcinoma (ATC) is an orphan disease and in most patients fatal. So far
no established treatment is available that prolongs survival. Several large retrospective …

Background. Anaplastic thyroid cancer (ATC) responds poorly to conventional therapies and
requires a multidisciplinary approach to manage. The aim of the current study is to explore …

Background Anaplastic thyroid carcinoma (ATC), accounting for 5% to 15% of primary
malignant thyroid neoplasms, is one of the most aggressive solid tumors in humans …

Opinion statement Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive tumor
characterized by rapid growth that causes death soon after diagnosis. Optimal treatment is …

BACKGROUND: ATC represents 1–2% of all thyroid carcinomas. Median survival is poor (3–
10 months). Our goal is to update recommendations for RT in the context of new irradiation …

Introduction. Anaplastic thyroid carcinoma (ATC) is rare yet accounts for up to 50% of all
thyroid cancer deaths. This study reviews outcomes of patients with confirmed ATC referred …

Context Anaplastic thyroid carcinoma (ATC) is an orphan disease and confers a dismal
prognosis. Standard treatment is not established. Objective The aim of this study is to …

OBJECTIVE: The aim of this study is to retrospectively describe the epidemiological and
clinical features, therapeutic modalities, prognostic factors and survival figures in a …

Background Anaplastic thyroid cancer (ATC) is an aggressive malignant tumour with a poor
prognosis. The median overall survival is described in the literature to be just 6 months …

Anaplastic Thyroid Carcinoma (ATC) is a rare thyroid tumor with a very aggressive clinical
course. The following is a report of five patients with inoperable locally advanced disease …